Taysha Gene Therapies Reports Q4 Earnings: $9.77M Revenue, -$0.34 EPS

jueves, 19 de marzo de 2026, 8:08 am ET1 min de lectura
TSHA--

Taysha Gene Therapies reported FY GAAP EPS of -$0.34, beating estimates by $0.02, and revenue of $9.77M, a 17.3% YoY increase and $3.47M above expectations.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios